Scinai Immunotherapeutics (SCNI) Cash from Operations Growth (5y) (2023 - 2026)

Scinai Immunotherapeutics (SCNI) Cash from Operations Growth (5y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,981.90 Bn	66,981.62 Bn	-
2	Nanobiotix	1,924.26 Bn	1,924.20 Bn	-
3	Akari Therapeutics	975.59 Bn	975.59 Bn	-
4	BeOne Medicines	472.11 Bn	467.32 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.89 Bn	114.65 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.93 Bn	61.18 Bn	3.31 Bn
7	Belite Bio	62.83 Bn	62.83 Bn	-
8	Argenx Se	55.82 Bn	50.63 Bn	1.41 Bn
9	Revolution Medicines	37.49 Bn	37.49 Bn	-
10	Scinai Immunotherapeutics	3.74 Bn	627.11 Mn	-1.12 Mn

Download Data